Among other topics, this program will address:
- Proxy access
- Shareholder proposal trends
- Say-on-pay and say-when-on-pay votes
- Voting policy changes from proxy advisory firms
- Board composition and trends
- Other trends in corporate governance
- SEC rulemaking update
Panelists
- Joshua Agen, Partner, Foley & Lardner LLP
- Curt Creely, Partner, Foley & Lardner LLP
- Richard Grubaugh, Senior Vice President, D.F. King & Co., Inc.
- Patrick McGurn, Special Counsel and Head of Strategic Research and Analysis, Institutional Shareholder Services
- John Wolfel, Partner, Foley & Lardner LLP
There is no cost to participate in this program, but pre-registration is required. To participate, please use the Register Today button above or below, or simply register here. Instructions for accessing the program will be sent in your confirmation email.
We look forward to having you join us. For more information, please visit Foley.com/NDI or contact Harrison Papadakis at [email protected].
Josh Agen, Curt Creely, and John Wolfel are the Foley attorneys responsible for this program.
People
Related Insights
April 28, 2026
Health Care Law Today
Medicare Payment Suspensions Emerge as a Key Tool in Federal Anti-Fraud Efforts — Focus on California Hospices
Medicare payment suspensions result in a cessation of payments for Medicare services until the suspension is resolved, typically several months after the initial action to suspend. Payments withheld will then be released after recoupment of any determined overpayments. The Trump Administration has stated that it will aggressively use its authority (created by the 2010 Affordable Care Act) to suspend payments based upon a credible allegation of fraud. Below we set forth the context for such suspensions, as well as the key parameters for such actions.
April 28, 2026
Health Care Law Today
Psychedelics and the Executive Order: From Schedule I to Treatment Priority
On April 18, 2026, President Donald Trump signed an executive order titled Accelerating Medical Treatments for Serious Mental Illness, directing federal agencies to expedite the research, review, and approval of psychedelic drugs as potential treatments for serious mental health conditions. The Order represents a significant federal policy shift aimed at addressing what the Trump Administration describes as a crisis of serious mental illness in America, with particular emphasis on patients whose conditions have not responded to standard therapies.
April 27, 2026
Labor & Employment Law Perspectives
The Elusive PAGA Early Evaluation Conference
According to the PAGA reform statute, employers with at least 100 employees can seek an Early Evaluation Conference within the time required to respond to the lawsuit to allow a neutral evaluator to decide a wide range of issues,